Literature DB >> 28984485

Exercise-induced bronchospasm in a hot and dry region: study of asthmatic, rhinitistic and asymptomatic adolescents.

Marco Aurélio de Valois Correia Junior1,2,3,4, Emília Chagas Costa3, Silvia Wanick Sarinho2, José Ângelo Rizzo2,3,4, Emanuel Sávio Cavalcanti Sarinho2,3.   

Abstract

BACKGROUND: Exercise-induced bronchospasm (EIB) is the bronchial narrowing that occurs after intense exercise in a significant number of asthmatics and in some non-asthmatics. This study aims to evaluate the occurrence of EIB in adolescents with asthma, rhinitis and respiratory asymptomatics in a hot and dry climate. RESEARCH DESIGN AND METHODS: This is a cross-sectional study based on an epidemiological study that evaluated the prevalence of asthma in schoolchildren in a semi-arid zone of Brazil. The EIB was defined as a reduction in forced expiratory volume in first second (FEV1) greater than 10%.
RESULTS: A total of 114 individuals participated in the study (36.8% male), of whom 54 were asymptomatic, 30 asthmatic and 30 with rhinitis. Asthmatics presented a higher proportion of EIB in comparison to rhinitis and asymptomatics (46.7% vs. 13.3% and 7.4%, p = 0.001) and none of the individuals had severe EIB (ΔFEV1 ≥ 50%).
CONCLUSIONS: A large proportion of the asthmatics selected from the community for the clinical study had EIB. Among participants with rhinitis, EIB was found in slightly more than 10%, while in the asymptomatics the frequency was slightly more than 5%. This study presents an important aspect in individuals living in hot and dry climates.

Entities:  

Keywords:  Asthma; air humidity; epidemiology; exercise-induced bronchospasm; rhinitis

Mesh:

Year:  2017        PMID: 28984485     DOI: 10.1080/17476348.2017.1389278

Source DB:  PubMed          Journal:  Expert Rev Respir Med        ISSN: 1747-6348            Impact factor:   3.772


  1 in total

Review 1.  Exercise-induced bronchoconstriction: prevalence, pathophysiology, patient impact, diagnosis and management.

Authors:  Bhumika Aggarwal; Aruni Mulgirigama; Norbert Berend
Journal:  NPJ Prim Care Respir Med       Date:  2018-08-14       Impact factor: 2.871

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.